National Cancer Institute
American Cancer Society
World Cancer Campaign
Int Agency for Research on Cancer

Never Give Up

Cancer Journal, Educational Resources, Advocacy Information


Stephen M. Apatow
Founder, Director of Research & Development
Humanitarian Resource Institute (UN:NGO:DESA)
Humanitarian University Consortium Graduate Studies
Center for Medicine, Veterinary Medicine & Law
Phone: 203-668-0282
Email: s.m.apatow@humanitarian.net
Internet: www.humanitarian.net

United Nations Arts Initiative
Internet: www.unarts.org

In The News:
Cancer Research & Development

In The Spotlight
Stephen Michael Apatow, Founder of Humanitarian Resource Institute, United Nations Arts Initiative, Director of Research and Development, Humanitarian University Consortium Graduate Studies Center for Medicine, Veterinary Medicine and Law is working to engage every level of the international biodefense, veterinary public health and the medical research community into cancer treatment and prevention.  Today, his objective is to establish Tumor Infiltrating Lymphocyte Therapy as a standard of care in conjunction with with advanced diagnostics and treatment:
Tumor Infiltrating Lymphocyte Therapy: A specific type of cell transfer immunotherapy, in which the lymphocytes infused back into the patient are from the patients own tumor.  These lymphocytes are actually infiltrating and trying to destroy the tumor and they are obtained when the tumor is biopsied or excised. The tumor infiltrating lymphocytes contain a large concentration of cytotoxic T lymphocytes specifically targeted against the antigens in the patients own tumor as well as numbers of natural killer lymphoctes that can destroy tumor cells .  The lymphocytes are grown in a laboratory with interleukin-2 to stimulate growth of the lymphocytes and then infused back into the patient to attack and destroy the tumor. -- Neoplastic Disease: An Introduction to Human Disease: Pathology and Pathophysiology Correlations, Leonard V. Crowley.

In patients with high grade glioma, little is known regarding existence of naturally occurring adaptive T cell reactivity against glioma-associated antigens (GAAs). In this report, we characterized GAA-specific CD8+ T cells and innate immune cells in a patient who has survived with anaplastic astrocytoma (AA) for over 12 years without recurrence. -- Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma: Journal of Translational Medicine 2007, 5:68. (Full Text).

Veterinary:  Biologics,  Anti-Cancer Research
  • Bioniche: Mycobacterial Cell Wall-DNA complex (MCC), Oligonucleotides.

Human Medicine:
Anti-Cancer Research

Back to the United Nations Arts Initiative.

Copyright 1994-2011 Humanitarian Resource Institute.  All rights reserved